Explore: Generative AI · Biotech · Drug Discovery · Growth · Seed · Series A
Dimension
Dimension is a venture capital firm investing in early-stage startups at the intersection of technology, artificial intelligence, and life sciences, particularly those melding compute and biology to transform drug discovery and biopharma.
Dimension invests at growth, seed, Series A and Series B, focuses on Generative AI, Biotech and Drug Discovery, backs founders in USA, New York and San Francisco.
Stages
growthseedSeries ASeries B
Sectors
Generative AIBiotechDrug Discovery
Geographies
USANew YorkSan Francisco
🔒 Team & partners
Sign in to view🔒 Live funding signals
Sign in to view🔒 Contacts
Sign in to viewSign in to see Dimension's full profile
Team & partners, portfolio, live funding signals and contacts. Free account, Google sign-in.
Create free accountVerified 26 March 2026 · Sources: company website, Fusion42 review
Frequently asked questions
- What does Dimension invest in?
- Dimension invests in Generative AI, Biotech and Drug Discovery at the growth, seed, series-a and series-b stages.
- Which geographies does Dimension focus on?
- Dimension focuses on USA, New York and San Francisco.